Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Blas

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Cancer Reports (Hoboken, N.J.)|March 5, 2024
Targeting HER2/HER3 co-mutations in metastatic breast cancer: Case reports of exceptional responders to trastuzumab and pertuzumab therapyPage E Blas, Esther San Roman Rodriguez, Heather L Williams, et al.
Communications Biology|October 15, 2024
Decoding sex-specific metabolomic biomarkers in the loggerhead sea turtle (Caretta caretta)P J Marín-García, D García-Párraga, J L Crespo-Picazo, et al.
Biomarker Research|July 25, 2023
Pilot clinical trial and phenotypic analysis in chemotherapy-pretreated, metastatic triple-negative breast cancer patients treated with oral TAK-228 and TAK-117 (PIKTOR) to increase DNA damage repair deficiency followed by cisplatin and nab paclitaxelJessica D Lang, Tuong Vi V Nguyen, Maren K Levin, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Cancer Reports (Hoboken, N.J.)|March 5, 2024
Targeting HER2/HER3 co-mutations in metastatic breast cancer: Case reports of exceptional responders to trastuzumab and pertuzumab therapyPage E Blas, Esther San Roman Rodriguez, Heather L Williams, et al.
Communications Biology|October 15, 2024
Decoding sex-specific metabolomic biomarkers in the loggerhead sea turtle (Caretta caretta)P J Marín-García, D García-Párraga, J L Crespo-Picazo, et al.
Biomarker Research|July 25, 2023
Pilot clinical trial and phenotypic analysis in chemotherapy-pretreated, metastatic triple-negative breast cancer patients treated with oral TAK-228 and TAK-117 (PIKTOR) to increase DNA damage repair deficiency followed by cisplatin and nab paclitaxelJessica D Lang, Tuong Vi V Nguyen, Maren K Levin, et al.
Pageof 3